Core transcription factors, Oct4, Sox2 and Nanog, individually form complexes with nucleophosmin (Npm1) to control

Helena Johansson1, Stina Simonsson

  • 1Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, box 440, 405 30 Gothenburg, Västra Götaland; Sweden.

Aging
|November 16, 2010
PubMed

Insights

Researchers identified novel protein interactions in embryonic stem (ES) cells. Nucleophosmin (Npm1) and translationally controlled tumor protein (Tpt1) are crucial for maintaining the ES cell phenotype and pluripotency.

Area of Science:

  • Stem cell biology
  • Molecular mechanisms of pluripotency
  • Protein-protein interactions

Background:

  • Embryonic stem (ES) cells hold significant therapeutic potential for regenerative medicine.
  • The precise molecular mechanisms governing ES cell pluripotency remain incompletely understood.
  • Proteins often participate in diverse cellular functions based on their interaction partners.

Purpose of the Study:

  • To identify novel protein-protein interactions involving core transcription factors in ES cells.
  • To elucidate the role of these interactions in maintaining ES cell pluripotency and phenotype.

Main Methods:

  • Screening for protein-protein interactions using in situ proximity ligation assays.
  • Utilizing specific antibodies against known key ES cell proteins.
  • Investigating protein complex stability during differentiation induced by retinoic acid.

Main Results:

  • Identified novel complexes between nucleophosmin (Npm1) and each of the core transcription factors: Oct4, Sox2, and Nanog.
  • Observed that the Npm1/Sox2 complex stability varied with differentiation pathways.
  • Discovered Oct4 also forms complexes with translationally controlled tumor protein (Tpt1).
  • Downregulation of Npm1 or Tpt1 led to increased mRNA levels for differentiation pathway genes.

Conclusions:

  • Described four new protein-protein interactions involving the three core ES cell transcription factors.
  • Enhanced understanding of ES cell-specific protein networks.
  • Highlighted the critical roles of Npm1 and Tpt1 in maintaining the ES cell phenotype and pluripotency.

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.
Maintenance of the ES Cell State01:14

Maintenance of the ES Cell State

The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Combinatorial Gene Control02:33

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...